Prescription Weight Loss Pills - Global and China Top Players Market Share and Ranking 2024
- Report Code : AMP2755389
- Published On: Jul, 2024
- Category : Healthcare & Pharma
- Pages : 141
-
According to Ample Market Research, the global market for Prescription Weight Loss Pills should grow from US$ 1130 million in 2022 to US$ 2625.3 million by 2029, with a CAGR of 10.4% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Prescription Weight Loss Pills market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Prescription Weight Loss Pills market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Pharmacy grew percent.
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
This report studies and analyses global Prescription Weight Loss Pills status and future trends, helps the client to determine the Prescription Weight Loss Pills market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Prescription Weight Loss Pills, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Prescription Weight Loss Pills market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Prescription Weight Loss Pills sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Prescription Weight Loss Pills sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Prescription Weight Loss Pills key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Prescription Weight Loss Pills key producing regions, capacity, production, and year over year growth
(6) Prescription Weight Loss Pills industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Novo Nordisk A/S
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Pfizer
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)
Market segment by Type, covers
Oral Tablets
Oral Capsules
Injections
Market segment by Application, can be divided into
Hospital
Pharmacy
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Prescription Weight Loss Pills product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Prescription Weight Loss Pills market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Prescription Weight Loss Pills market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Prescription Weight Loss Pills, percent & CAGR, 2019-2030
Chapter 5: Prescription Weight Loss Pills industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
-
With tables and figures helping analyze worldwide Prescription Weight Loss Pills Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Prescription Weight Loss Pills Definition
1.2 Global Prescription Weight Loss Pills Market Size and Forecast
1.2.1 By Consumption Value, Global Prescription Weight Loss Pills Market Size，2019-2030
1.2.2 By Sales Quantity, Global Prescription Weight Loss Pills Market Size，2019-2030
1.2.3 Global Prescription Weight Loss Pills Average Selling Price (ASP)，2019-20301.3 China Prescription Weight Loss Pills Market Size and Forecast
1.3.1 By Consumption Value, China Prescription Weight Loss Pills Market Size，2019-2030
1.3.2 By Sales Quantity, China Prescription Weight Loss Pills Market Size，2019-2030
1.3.3 China Prescription Weight Loss Pills Average Selling Price (ASP)， 2019-20301.4 Share of China Prescription Weight Loss Pills Market with Respect to the Global Market
1.4.1 By Consumption Value, China Prescription Weight Loss Pills Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Prescription Weight Loss Pills Market Share in Global, 2019-2030
1.4.3 Prescription Weight Loss Pills Market Size: China VS Global, 2019-20301.5 Prescription Weight Loss Pills Market Dynamics
1.5.1 Prescription Weight Loss Pills Market Drivers
1.5.2 Prescription Weight Loss Pills Market Restraints
1.5.3 Prescription Weight Loss Pills Industry Trends
1.5.4 Prescription Weight Loss Pills Industry Policy
2 Global Leading Manufacturers and Market Share2.1 By Revenue of Prescription Weight Loss Pills, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Prescription Weight Loss Pills, Global Market Share by Company, 2019-2024
2.3 Prescription Weight Loss Pills Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Prescription Weight Loss Pills Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Prescription Weight Loss Pills Concentration Ratio
2.6 Global Prescription Weight Loss Pills Mergers & Acquisitions, Expansion Plans
2.7 Global Prescription Weight Loss Pills Manufacturers Product Type
2.8 Head Office and Prescription Weight Loss Pills Production Site of Key Manufacturer
2.9 Prescription Weight Loss Pills Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share3.1 By Revenue of Prescription Weight Loss Pills, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Prescription Weight Loss Pills, China Market Share by Company, 2019-2024
3.3 China Prescription Weight Loss Pills Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions4.1 Global Prescription Weight Loss Pills Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Prescription Weight Loss Pills Capacity by Region
4.3 Global Prescription Weight Loss Pills Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Prescription Weight Loss Pills Production by Region, 2019-2030
4.5 Global Prescription Weight Loss Pills Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis5.1 Prescription Weight Loss Pills Industry Chain
5.2 Prescription Weight Loss Pills Upstream Analysis
5.2.1 Prescription Weight Loss Pills Core Raw Materials
5.2.2 Main Manufacturers of Prescription Weight Loss Pills Core Raw Materials5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prescription Weight Loss Pills Production Mode
5.6 Prescription Weight Loss Pills Procurement Model
5.7 Prescription Weight Loss Pills Industry Sales Model and Sales Channels
5.7.1 Prescription Weight Loss Pills Sales Model
5.7.2 Prescription Weight Loss Pills Typical Distributors
6 Sights by Type6.1 Prescription Weight Loss Pills Classification
6.1.1 Oral Tablets
6.1.2 Oral Capsules
6.1.3 Injections6.2 By Type, Global Prescription Weight Loss Pills Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Prescription Weight Loss Pills Consumption Value, 2019-2030
6.4 By Type, Global Prescription Weight Loss Pills Sales Quantity, 2019-2030
6.5 By Type, Global Prescription Weight Loss Pills Average Selling Price (ASP), 2019-2030
7 Sights by Application7.1 Prescription Weight Loss Pills Segment by Application
7.1.1 Hospital
7.1.2 Pharmacy7.2 By Application, Global Prescription Weight Loss Pills Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Prescription Weight Loss Pills Consumption Value, 2019-2030
7.4 By Application, Global Prescription Weight Loss Pills Sales Quantity, 2019-2030
7.5 By Application, Global Prescription Weight Loss Pills Price, 2019-2030
8 Sales Sights by Region8.1 By Region, Global Prescription Weight Loss Pills Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Prescription Weight Loss Pills Consumption Value, 2019-2030
8.3 By Region, Global Prescription Weight Loss Pills Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Prescription Weight Loss Pills & Forecasts, 2019-2030
8.4.2 By Country, North America Prescription Weight Loss Pills Market Size Market Share8.5 Europe
8.5.1 Europe Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Prescription Weight Loss Pills Market Size Market Share8.6 Asia Pacific
8.6.1 Asia Pacific Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Prescription Weight Loss Pills Market Size Market Share
8.7 South America
8.7.1 South America Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Prescription Weight Loss Pills Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level9.1 By Country, Global Prescription Weight Loss Pills Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Prescription Weight Loss Pills Consumption Value, 2019-2030
9.3 By Country, Global Prescription Weight Loss Pills Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Prescription Weight Loss Pills Market Size, 2019-2030
9.4.2 By Type, U.S. Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.4.3 By Application, U.S. Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 20309.5 Europe
9.5.1 Europe Prescription Weight Loss Pills Market Size, 2019-2030
9.5.2 By Type, Europe Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.5.3 By Application, Europe Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 20309.6 China
9.6.1 China Prescription Weight Loss Pills Market Size, 2019-2030
9.6.2 By Type, China Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.6.3 By Application, China Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan Prescription Weight Loss Pills Market Size, 2019-2030
9.7.2 By Type, Japan Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.7.3 By Application, Japan Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea Prescription Weight Loss Pills Market Size, 2019-2030
9.8.2 By Type, South Korea Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.8.3 By Application, South Korea Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Prescription Weight Loss Pills Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.9.3 By Application, Southeast Asia Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 20309.10 India
9.10.1 India Prescription Weight Loss Pills Market Size, 2019-2030
9.10.2 By Type, India Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.10.3 By Application, India Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Prescription Weight Loss Pills Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
9.11.3 By Application, Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share, 2024 VS 2030
10 Manufacturers Profile10.1 Currax Pharmaceuticals (Contrave)
10.1.1 Currax Pharmaceuticals (Contrave) Company Information, Head Office, Market Area, and Industry Position
10.1.2 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Models, Specifications, and Application
10.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Currax Pharmaceuticals (Contrave) Company Profile and Main Business
10.1.5 Currax Pharmaceuticals (Contrave) Recent Developments10.2 VIVUS (Qsymia)
10.2.1 VIVUS (Qsymia) Company Information, Head Office, Market Area, and Industry Position
10.2.2 VIVUS (Qsymia) Prescription Weight Loss Pills Models, Specifications, and Application
10.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 VIVUS (Qsymia) Company Profile and Main Business
10.2.5 VIVUS (Qsymia) Recent Developments10.3 Novo Nordisk A/S
10.3.1 Novo Nordisk A/S Company Information, Head Office, Market Area, and Industry Position
10.3.2 Novo Nordisk A/S Prescription Weight Loss Pills Models, Specifications, and Application
10.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Novo Nordisk A/S Company Profile and Main Business
10.3.5 Novo Nordisk A/S Recent Developments10.4 Rhythm Pharmaceuticals (Imcivree)
10.4.1 Rhythm Pharmaceuticals (Imcivree) Company Information, Head Office, Market Area, and Industry Position
10.4.2 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Models, Specifications, and Application
10.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Rhythm Pharmaceuticals (Imcivree) Company Profile and Main Business
10.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments10.5 Eli Lilly and Company (TRICARE)
10.5.1 Eli Lilly and Company (TRICARE) Company Information, Head Office, Market Area, and Industry Position
10.5.2 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Models, Specifications, and Application
10.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Eli Lilly and Company (TRICARE) Company Profile and Main Business
10.5.5 Eli Lilly and Company (TRICARE) Recent Developments10.6 CHEPLAPHARM (Xenical)
10.6.1 CHEPLAPHARM (Xenical) Company Information, Head Office, Market Area, and Industry Position
10.6.2 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Models, Specifications, and Application
10.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 CHEPLAPHARM (Xenical) Company Profile and Main Business
10.6.5 CHEPLAPHARM (Xenical) Recent Developments
10.7 Pfizer
10.7.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.7.2 Pfizer Prescription Weight Loss Pills Models, Specifications, and Application
10.7.3 Pfizer Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Pfizer Company Profile and Main Business
10.7.5 Pfizer Recent Developments
10.8 Teva Pharmaceutical (Actavis)
10.8.1 Teva Pharmaceutical (Actavis) Company Information, Head Office, Market Area, and Industry Position
10.8.2 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Models, Specifications, and Application
10.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Teva Pharmaceutical (Actavis) Company Profile and Main Business
10.8.5 Teva Pharmaceutical (Actavis) Recent Developments
10.9 Haleon Group (alli)
10.9.1 Haleon Group (alli) Company Information, Head Office, Market Area, and Industry Position
10.9.2 Haleon Group (alli) Prescription Weight Loss Pills Models, Specifications, and Application
10.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Haleon Group (alli) Company Profile and Main Business
10.9.5 Haleon Group (alli) Recent Developments10.10 Sanofi (Adlyxin)
10.10.1 Sanofi (Adlyxin) Company Information, Head Office, Market Area, and Industry Position
10.10.2 Sanofi (Adlyxin) Prescription Weight Loss Pills Models, Specifications, and Application
10.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Sanofi (Adlyxin) Company Profile and Main Business
10.10.5 Sanofi (Adlyxin) Recent Developments
10.11 AstraZeneca (BYDUREON BCise)
10.11.1 AstraZeneca (BYDUREON BCise) Company Information, Head Office, Market Area, and Industry Position
10.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Models, Specifications, and Application
10.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 AstraZeneca (BYDUREON BCise) Company Profile and Main Business
10.11.5 AstraZeneca (BYDUREON BCise) Recent Developments
11 Conclusion
12 Appendix12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources12.3 Market Estimation Model
12.4 Disclaimer
-
The Prescription Weight Loss Pills Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Prescription Weight Loss Pills Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
It is expected that the Prescription Weight Loss Pills Global and China Top Players Market will reach USD XX million by 2029.
The Prescription Weight Loss Pills Global and China Top Players Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
In this highly competitive and rapidly evolving Prescription Weight Loss Pills Global and China Top Players Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
